Impro Precision Industries (1286) H2 2025 earnings summary

Executive summary

• Revenue grew 8.7% year-over-year to HK$5,095.5M in 2025, driven by strong performance in AI-related products and medical end-markets, with high horsepower engine and diversified industrials also contributing.

• Adjusted profit attributable to shareholders rose 12.1% to HK$689.9M, while profit attributable to shareholders reached a record HK$726.2M, and basic EPS increased to 38.5 HK cents.

• Gross profit margin improved to 27.5%, with gross profit up 10.3% to HK$1,400.1M and sand casting margin up 2.6% to 31.2%.

• Operating cash flow increased 9.8% to HK$1,258.7M, supporting stable free cash flow and dividend payout.

• Dividend per share maintained at 16.0 HK cents, with a 44% payout ratio on adjusted profit.

Financial highlights

• Adjusted EBITDA rose 7.2% to HK$1,413.1M (margin 27.7%); EBITDA up 1.6%.

• Net assets grew to HK$5,623.2M as of December 31, 2025; total assets increased 14.9% to HK$9,389.9M.

• Free cash inflow from operations declined 38.4% to HK$281.6M.

• Net debt increased 7.2% to HK$1,709.9M; net gearing ratio at 30.4%.

• Operating expenses remained stable as a percentage of revenue.

Outlook and guidance

• Sales revenue growth rate expected to accelerate over the next two to three years, with 2026 sales growth forecast at mid-double digits.

• Anticipated strong growth in AI-related products, diversified industrials, and new orders from Mexico SLP Campus.

• High horsepower engine components expected to enter a new growth curve in 2026 with expanded capacity in Mexico.

• Aerospace, energy, and medical sectors to become primary growth engines, with potential spin-off and separate listing under evaluation.

• Ample liquidity with ~HK$2.5B undrawn banking facilities to support strategic initiatives.